Back

RE-CIRCUIT and reversal: how will our practice change?

19 June 2017 (13:15 - 13:35)
Organised by:
Congress Presentation Part of: RE-CIRCUIT: uninterrupted dabigatran as a new strategy in atrial fibrillation ablation Atrial fibrillation ablation EHRA Premium Access EHRA EUROPACE - CARDIOSTIM 2017

About the speaker

Photo
Doctor Hugh Calkins

The Johns Hopkins Hospital, Baltimore (United States of America)

3 More presentations in this session

Presentation thumbnail
Anticoagulation care in the electrophysiology lab: what do we know so far?
Professor G. Lip (Liverpool, GB)
Presentation thumbnail
New evidence on periprocedural strategies for atrial fibrillation ablation: the RE-CIRCUIT trial.
Professor S. Willems (Hamburg, DE)
Presentation thumbnail
Audience Q&A.
Professor G. Lip (Liverpool, GB)

Access the full session

Session thumbnail
RE-CIRCUIT: uninterrupted dabigatran as a new strategy in atrial fibrillation ablation

The Event

Event poster

EHRA EUROPACE - CARDIOSTIM 2017

19 June 2017 13:15 CET
You may be interested in
thumbnail
Congress Presentation
Successful Marshall-Plan ablation strategy for long-standing persistent atrial fibrillation in a patient with situs inversus totalis
13 April 2026
thumbnail
Congress Session
What’s on the horizon in heart failure: precision medicine and tailored treatment
18 May 2025
thumbnail
Congress Presentation
In-silico mechanistic interpretation of echocardiographic predictors of reverse remodeling after cardiac resynchronization therapy
30 August 2026
thumbnail
ESC TV Today
Episode 17: Coronary sinus reducer - Best strategies to reach LDL cholesterol goals
5 June 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources